Want to see IL:CANF full AI Analyst Report?
Total Valuation
Can Fite Bio has a market cap or net worth of ₪15.98M. The enterprise value is -5.67M.
Market Cap₪15.98M
Enterprise Value-5.67M
Share Statistics
Can Fite Bio has 6,070,627 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,070,627
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Can Fite Bio’s return on equity (ROE) is -1.90 and return on invested capital (ROIC) is -157.46%.
Return on Equity (ROE)-1.90
Return on Assets (ROA)-1.12
Return on Invested Capital (ROIC)-157.46%
Return on Capital Employed (ROCE)-1.59
Revenue Per Employee87.68K
Profits Per Employee-1.97M
Employee Count5
Asset Turnover0.05
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Can Fite Bio is ―. Can Fite Bio’s PEG ratio is >-0.00001.
PE Ratio―
PS Ratio35.39
PB Ratio2.77
Price to FCF-1.60
Price to Operating Cash Flow-0.33
PEG Ratio>-0.00001
Income Statement
In the last 12 months, Can Fite Bio had revenue of 438.40K and earned -10.64M in profits. Earnings per share was -6.46.
Revenue438.40K
Gross Profit412.42K
Operating Income-10.77M
Pretax Income-10.64M
Net Income-10.64M
EBITDA-10.74M
Earnings Per Share (EPS)-6.46
Cash Flow
In the last 12 months, operating cash flow was -9.51M and capital expenditures -2.00K, giving a free cash flow of -9.51M billion.
Operating Cash Flow-9.51M
Free Cash Flow-9.51M
Free Cash Flow per Share-1.57
Dividends & Yields
Can Fite Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.47
52-Week Price Change26230.00%
50-Day Moving Average375.97
200-Day Moving Average526.77
Relative Strength Index (RSI)16.54
Average Volume (3m)12.95K
Important Dates
Can Fite Bio upcoming earnings date is Apr 1, 2027, Before Open (Confirmed).
Last Earnings DateSep 8, 2026
Next Earnings DateApr 1, 2027
Ex-Dividend Date―
Financial Position
Can Fite Bio as a current ratio of 3.46, with Debt / Equity ratio of 1.01%
Current Ratio3.46
Quick Ratio3.46
Debt to Market Cap0.00
Net Debt to EBITDA0.51
Interest Coverage Ratio-710.74
Taxes
In the past 12 months, Can Fite Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Can Fite Bio EV to EBITDA ratio is -0.94, with an EV/FCF ratio of -1.04.
EV to Sales22.94
EV to EBITDA-0.94
EV to Free Cash Flow-1.04
EV to Operating Cash Flow-1.04
Balance Sheet
Can Fite Bio has ₪7.04M in cash and marketable securities with ₪49.00K in debt, giving a net cash position of ₪6.99M billion.
Cash & Marketable Securities₪7.04M
Total Debt₪49.00K
Net Cash₪6.99M
Net Cash Per Share₪1.15
Tangible Book Value Per Share₪3.39
Margins
Gross margin is 100.00%, with operating margin of -2456.79%, and net profit margin of -2426.67%.
Gross Margin100.00%
Operating Margin-2456.79%
Pretax Margin-2426.67%
Net Profit Margin-2426.67%
EBITDA Margin-2450.87%
EBIT Margin-2456.79%
Analyst Forecast
The average price target for Can Fite Bio is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―